
TEM Stock Forecast & Price Target
TEM Analyst Ratings
Bulls say
Tempus AI is a promising investment due to its focus on healthcare and AI, as well as its strong financial targets and potential for new acquisitions. Recent partnerships and positive performance indicate a growth in stock price target. With a projected revenue of $1.95 billion in 2026, strong revenue increase in Q3'25, and a Buy rating from analysts, Tempus AI has the potential for a 30%+ CAGR. However, competition and potential market share loss are important factors to consider when evaluating the company's future prospects.
Bears say
Tempus AI is currently facing challenges with its profitability, as adjusted EBITDA came in below analyst estimates for Q3. Additionally, their revenue growth is heavily reliant on the success of their genomics segment, which is dependent on reimbursement rates. Without a strong increase in growth and profitability, it is unlikely that their current valuation of 15x FY26 revenue estimates will be achieved.
This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.
TEM Analyst Forecast & Price Prediction
Start investing in TEM
Order type
Buy in
Order amount
Est. shares
0 shares